Sign In to Follow Application
View All Documents & Correspondence

"Chloromethylation Of Thiophene"

Abstract: The process according to the invention relates to the proparation of 2 chloromethyl thiophene of the formula (I) During this process thiophene is chloromethylated in the presence of one or more compounds containing keto group and optionally it is transformed into the compound of the formula (II) Compound of formula (I) and (II) are intrmediates of several pharmaccutically active ingredients.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
24 October 2003
Publication Number
39/2005
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2011-06-09
Renewal Date

Applicants

SANOFI-SYNTHELABO
174, AVENUE DE FRANCE, F-75013 PARIS, FRANCE.

Inventors

1. MATYAS ARADI
BUDAPEST, SARPATAK U.3., H-1046 HUNGARY.
2. FERENC BAKOS
BUDAPEST NAP U. 3., H01045 HUNGARY.
3. ZSOLT DOMBRADY
BUDAPEST, SOLYOM U. 10., H-1126 HUNGARY.
4. ANTAL GAJARY
BUDAPEST BOLONI GY. U. 12/B, H-1021, HUNGARY.
5. ISTAVAN GYONGYOSI
BUDAPEST, NAGY L.K. UTIJA 96/B, H-1148, HUNGARY.
6. FERENC KOVACS
BUDAPEST, DRDOSOR U. 22., H-1046 HUNDARY.
7. ANDREA MAJOR
BUDAPEST, LZZO U. 5., H-1047, HUNGARY.
8. ERIKA MATENE TOROK
NAGYTARCSA, PETOFI HP 14/K/9, H-2142 HUNGARY.
9. ZSOLT PARKANYI
BUDAPEST, KELETI K. U. 13/B, H-2035 HUNGARY.
10. LASZLO SCHULTZ
BUDAPEST, DREGELY U. 5., H-1097 HUNGARY.
11. ATTILA SUPIC
BUDAPEST, GERGELY U. 48., H-1103 HUNGARY.
12. SANDOR SZABO
BUDAPEST, BELGARD RKP. 23., H-1056 HUNGARY.
13. ERZSEBET SZALAY
BUDAPEST, DAMJANICH U. 23., H-1071 HUNGARY.
14. JOZSEF UGRICS
BUDAPEST, SZENTMIHALYI U. 12-14, H-1144 HUNGARY.
15. JOZSEF ZSIGA
DUNAKESZI, BARATSAG U. 35., H-2120 HUNGARY.

Claims

1. A process for the preparation of a compound of the formula (I) (Formula Removed) by chloromethylation of thiophene, characterized in that, the chloromethylation is carried out in the presence of one or more compounds containing keto-group of formula (V) (Formula Removed) wherein the meanings of Rl and R2 are other than hydrogen.

2. A process as claimed in claim 1, wherein, the chloromethylation is carried out in a dialkyl-ketone type solvent.

3. A process as claimed in claim 2, wherein, the chloromethylation is carried out in acetone or methyl-ethyl-ketone or methyl-isobutyl-ketone.

4. A process as claimed in claim 1, wherein, the chloromethylation is carried out between - 15°Cand + 20°C.

5. A process as claimed in claim 1, wherein, the chloromethylation is carried out by using aqueous concentrated hydrochloric acid, gaseous hydrogen chloride and paraformaldehy de.

6. A process as claimed in claim 5, wherein, the dry hydrogen chloride gas is introduced into the reaction mixture or it is used after absorption in a compound containing keto- group.

7. A process as claimed in claim 5, wherein, the molar ratio of thiophene, aqueous hydrochloric acid, gaseous hydrogen chloride and paraformaldehyde is 1,0:1,0 - 1,3:0,75- 1,0:1,0.

8. A process as claimed in claim 1, wherein, 1-3 volume units, most preferably 2,0-2,6 volume units compound containing keto-group are used counted to 1 volume unit of thiophene.

9. A process as claimed in claim 5, wherein, an anorganic sait, preferably calcium-chloride is dissolved in the used aqueous hydrogen chloride solution.

10. A process as claimed in claim 1, wherein, the received compound of the formula (I) is transformed further into a compound of the formula (II) (Formula Removed)

11. A process as claimed in claim 1, wherein, the formed compound of the formula (I) is transformed further without isolation into a compound of the formula (II).

12. A process as claimed in claim 9, wherein, the received compound of the formula (I) is transformed into a compound of the formula (II) by using aqueous alkali cyanide optionally in the presence of phase-transfer catalyst.

13. A process as claimed in claim 1, wherein the compounds of formula I are used for the synthesis of different Active Pharmaceutical Ingredients.

14. A process as claimed in claim 10, wherein the compounds of formula II are used for the synthesis of different Active Pharmaceutical Ingredients.

Specification

CHLOROMETHYLATION OF THIOPHENE
This invention relates to a new process for the preparation of 2-chloromethyl-tiophene of
the formula (I) and lor the preparation of the 2-thienyl-acctonitrile of the formula (II)
starting from tiophene.
Compounds of the formula (I) and (II) are valuable intermediates for the pharmaceutical
industry. For example the 2-thienyl-ethylamine of the formula (III) prepared from them is
the starting material of several Active Pharmaceutical Ingredients (API's).
The compound of the formula (I) is known for ages (Berichte 19) S. 636 (1886). It boils at
175°C under atmospheric pressure, it is a colourless oily liquid. It is a strong irritant for the
mucous membranes and for the skin. It is a labile compound, it has a tendency to
decompose and polimerize with explosive violence.
The compound of the formula (I) may be prepared by chloromethylation using
hydrochloric acid and formaldehyde, but considerable amount of heavily separable side
product appears during the reaction (J. Amcr. Chem. Soc. 64 (3) p 477 (1942)) and the
yield of the reaction is weak (Org. Synth. Coll. 3 p 197 (1955)).
There were several attempts to increase the yield of the chloromethylation and the purity of
the compound of the formula (I) thus obtained.
According to the US-2527680 cold concentrated aqueous hydrochloric acid and cold
aqueous formaldehyde solution were mixed, the mixture was saturated by hydrogen
chloride gas and this was added gradually to the tiophene at -10°C and the temperature of
he reaction mixture was maintained below +1°C. The reaction mixture, which became
biphasic after addition of water, was separated and the compound of the formula (I) was
yielded by the fractional destination with a yield of 61.8%. Significant amount (20-28%)
of side product was received, which was first of all bis-2-chloromethyl-tiophene and the
target compound of the formula (I) was contaminated by this compound.
According to the US Patent No 4501903 dry hydrogen chloride gas was introduced into the
mixture of tiophene, formaldehyde and concentrated hydrochloric acid at (-5°C) -
(-10°C) during heavy stirring with a rate of 0.3 - 1.5 mol / mol tiophene / hour. After that
the reaction mixture was diluted by water, it was left to stand at (-5°C) - (-10"C) and
among the dividing phases the organic phase contained 60-75% compound of the formula
(I). The yield of compound of the formula (I) fluctuated between 65-75%. The obtained
compound of the formula (T) contained the following impurities: 2,5-dichloromcthyl-

thiophene, chloromethyl-bis-thienyl-methane, bis-thienyl-metbane, thiophene and
polimers.
The above impurities and the 2-chloromethyl-5-hydroxy-methyl-thiophene, the 3-chloromethyl-thiophene of the formula (IV)and the 2-thineyl-methanol are present in the thiophene products of the formula (I) obtained by all process known from the prior art. The impurities listed make difficult the transformation of the non-isolated compound of the formula (I) into the compound of the formula (II), because they cause significant tar-production and the corresponding 3-cyano-derivative is a heavily separable impurity with a very close boiling point.
Furthermore the compound of the formula (IV) is transformed into the analogs of the API's syntheses and their separation during the syntheses or the resolution of the racemic API's or during the salt formation or the purification of the end products is extremely difficult. Therefore the amount of the 3-chloromethyl-thiophene of the formula (IV) and its cyano-or amine-derivative should be below the 0.3 mass % in the early intermediates (compounds of the formula (I), (II) and (III).
The isolation and the purification by vacuum distillation of the compound of the formula (I) is hazardous and not too efficient.
With this knowledge it was set as aim to find a process, which results a much purer compound of the formula (I) containing less than 0.3 mass% of 3-chloromcthyl-thiophene of the formula (IV), the process makes avoidable the isolation of the compound of the formula (I) and results the preparation of the compound of the formula (II) containing no tar.
A further aim was to find a process, which eliminate (he strong stirring, the appearance of a biphasic system and the emulsion during the process and remove the fluctuation of the yield depending on the rate of the introduction of hydrogen chloride gas. An another aim was to increase ihc yield in comparison with the known processes and to find a process which can be scaled up without the deterioration of the quality of the product.
Unexpectedly it has been found thai if the chloromclhylation of the thiopbenc is carried out in the presence of a compound containing a keto-group, then a much purer compound of the formula (1) is yielded of which 3-chloromclhyl-thiophaene content is well below the 0.3 mass% limit and optionally in the presence of a compound containing a keto-group without disturbing tar-formation it can be transformed into the compound of the formula (II). The yield and the technical characters of this invented process fulfilled the aimed parameters.

According to the invention thiophene is chloromethylated in the presence of one or more
compounds containing keto -group.
Preferably such compounds are applicable, which have a melting point below -15°C and a boiling point below +250"C. -
Such compounds are for example the dimethyl-ketone, diethyl-ketone, dipropyl-ketone, methyl-ethyl-ketone, methyl-propyl-ketone, methyl-isopropyl-ketone, methyl-butyl-ketone, methyl-isobutyl-ketone, methyl-terc.-butyl-ketone, methyl-pentyl-ketone and methyl-hexyl-ketone.
The chloromethylating agents used in the invented process are preferably concentrated aqueous hydrochloric acid, hydrogen chloride gas and formaldehyde or its polimers, for example the paraformaldheyde. The chloromethylation can be carried out in several ways according to the invention, for example thiophene is mixed with the compound containing keto-group and this mixture can be added to the mixture of concentrated aqueous hydrochloric acid and formaldehyde and then hydrogen chloride gas is introduced into the reaction mixture. It is also possible that the mixture of tiophene and the compound containing the keto -group is saturated with hydrogen chloride gas and then a mixture of formaldehyde and hydrochloric acid is added to it. This process variant is especially advantageous in case of large scale production.
The chloromethylation is carried out preferably between -15°C and +20°C, the temperature range between 0"C and 4 10°C is the most advantageous. The molar ratio of the reagents and the thiophene corresponds to the usual ratio used during the chloromethylation, the following molar ratio is the most preferred:
thiophcne: aqueous hydrochloric acid : hydrogen gas : paraformaldehyde = 1,0 : 1,0 -1.3 : 0.75- 1,0: 1,0.
The volumetric ratio of thiophene and the compound containing keto -group can be changed in a broad range preferred the ratio of 1:1-3 and the most preferred thiophcnc -kcto-compound ratio is 1 : 2.0-2,6.
In case of some representatives of keto compounds it is advantageous to dissolve inorganic salts in the aqueous hydrochloric acid in order to help the breaking of the reaction mixture. The compound of the formula (I) can be isolated by procedure well known in the art or without isolation after setting the pH of the reaction mixture to neutral it can be transformed by well-known organochemical methods into the compound of the formula (II) preferred procedure is a reaction with alkaline metal cyanides, for example with

sodium cyanide or potassium cyanide, optionally in the presence of a phase transfer
catalysator (for example tetra-butyl-ammonium halogenides). The compound of the formula (II) can be isolated by methods known per se. The compound of formula (II) may be transformed into the amine of the formula (III) and into different API's.
Further details of the present invention are illustrated by the following examples without restricting our claim to them. Figure 1 shows formula (I), Figure 2 shows formula (II), Figure 3 shows formula (III) and Figure 4 shows formula (IV).
Examples
Example 1
Into the suspension containing 84 g ( 1 mol) of tliiophene, 168 g of methyl-isobutyl-ketone,
100 g (1 mol) of aqueous hydrochloric acid (37%) and 30 g (1,0 mol) of paraformaldehyde
(Manufacturer: Degussa, number of monomeric units is between 4-98) at 0°C - (+5°C)
during 6 hours 36.5 g (1 mol) of hydrogen chloride gas was introduced. After stopping the
gas introduction the reaction mixture was stirred over a period of 1 hour 0°C - (+5°C).
After that the reaction mixture was diluted with 90 g of water, the organic phase was
washed with 50 g of 20% potassium carbonate solution to the neutral pH. The composition
of the reaction mixture was determined by gas chromatography and was the following
(area %): tliiophene 30.3%, 2-chloro-methyl-thiophene 61%, 3-chloromethyl-thiophcne
0.2%, 2,5-dichloromcthyl-thiophene 1.1%, bis-thienyl-methanc 6.7%, chloromethyl-bis-
thicnyl-methane 0.2%.
The non-reaclcd thiophenc (25 g) and the mcthyl-isobutyl-kctonc were removed in vacuum
by distillation.
The amount of the obtained crude 2-chloromcthyl-thiophcne is 75 g (81%).
Example 2
In the mixture of 84 g (1 mol) of thiophene and 168 g of methyl-isobut) 1-k.etonc (their volumetric ratio is 1 : 2.5) between 0°C and 15°C 27.3 g (0.75 mol) of hydrogen chloride were absorbed. In 130 g (1.25 mol) 37% of aqueous hydrochloric acid, 30 g (I mol) of paraformaJdchyde were dissolved (Manufacturer Degussa, number of monomer units is between 4 - 98) at 60°C and the solution was cooled to 20-25°C and this mixture was added to the mixture containing thiophene over a period of 4-6 hours between 0°C -(+5°C). After the end of feeding the mixture was diluted with 90 g of water and the organic

phase was separated and it was wasted with 50 g of 20% potassium carbonate solution. The
non-reacted thiophcne, 24 g and the mcthyl-isobutyl-ketone were removed by vacuum-distillation and 74.1 g (80%) of 2-chloromethyl-thiophene were received. Its quality was the same as in case of the product of Example 1
Example 3
All steps were identical with the procedure described in Example 1 but instead of methyl-isobutyl-ketone 168 g of acetone were used and for the breaking of the reaction mixutre 90 g of 30 mass% of calcium chloride solution were used because of the solubility of the acetone. 74.6 g (80.5%) of 2-chloromethyl-thiophene were obtained, its quality was the same as in case of the product of Example 1.
Example 4
All steps were identical with the procedure of Example 3 but instead of acetone 168 g of methyl-ethyl-ketone were used. 74.3 g (80.2%) 2-chloromethyl-thiophene were obtained. Its quality was the same as in case of the product of Example 1 .
Example 5
All steps were identical with the procedure of Example 1 but 30 g of calcium chloride were dissolved in 100 g of 37% aqueous hydrochloric acid. Thus the addition of 90 g of water was not necessary and the washing to neutral pH was carried out immediately. 74.1 g (80%) of 2-chloromethyl-thiophcne were obtained, its quality was the same as in case of the product of Example 1 .
Example 6
Preparation of 2-thienyl-ncetonitrilc of the formula (II) without the isolation of 2-
chloromcthyl -thiophcne of the formula (I)
The crude 2-chlorometh} l-thiopbene obtained according to Example I washed with 20
mass % of potassium carbonate to neutral pH and separated from the non-reacted
thiophene and the methyl-isobutyl-thiophene was added to 49 p (I mmol) of sodium cyanide
and 4 g of tclrabutyl-ammonium-bromidc, both dissolved in 150 g of water at 60°C. The
mixture was stirred at 70°C for 4 hours and then 1 60 g of water were added thereto, at
40°C, the aqueous and the organic phase were separated. The upper organic phase was

washed twice with 50 g of water and the ketone-thiophene mixture was removed by
distillation.
Thus 64 g (68%) of distilled 2-thienyl-acetonitrile were obtained, which had the following
composition in area % measured by gas chromatography:
2-thienyl-acetonitrile 87.7%
3-thienyl-acetonitrile 0.2%
2-thienyl-alcohol 3.7%
3-thienyl-aIcohol 0.2%
methyl-isobutyl-ketone 0.4%
bis-thienyl-ethane 1.8%
From the above crude product a 2-thienyl-acetonitrile product with 99.5% purity was obtained in which the 3-thienyl-acetonitrile content is 0.1%.

We Claim:
1. A process for the preparation of a compound of the formula (I)
(Formula Removed) by chloromethylation of thiophene, characterized in that, the chloromethylation is carried out in the presence of one or more compounds containing keto-group of formula (V)
(Formula Removed)
wherein the meanings of Rl and R2 are other than hydrogen.
2. A process as claimed in claim 1, wherein, the chloromethylation is carried out in a
dialkyl-ketone type solvent.
3. A process as claimed in claim 2, wherein, the chloromethylation is carried out in acetone
or methyl-ethyl-ketone or methyl-isobutyl-ketone.
4. A process as claimed in claim 1, wherein, the chloromethylation is carried out between -
15°Cand + 20°C.
5. A process as claimed in claim 1, wherein, the chloromethylation is carried out by using
aqueous concentrated hydrochloric acid, gaseous hydrogen chloride and
paraformaldehy de.
6. A process as claimed in claim 5, wherein, the dry hydrogen chloride gas is introduced
into the reaction mixture or it is used after absorption in a compound containing keto-
group.
7. A process as claimed in claim 5, wherein, the molar ratio of thiophene, aqueous
hydrochloric acid, gaseous hydrogen chloride and paraformaldehyde is 1,0:1,0 - 1,3:0,75-
1,0:1,0.
8. A process as claimed in claim 1, wherein, 1-3 volume units, most preferably 2,0-2,6
volume units compound containing keto-group are used counted to 1 volume unit of
thiophene.
9. A process as claimed in claim 5, wherein, an anorganic sait, preferably calcium-chloride
is dissolved in the used aqueous hydrogen chloride solution.
10. A process as claimed in claim 1, wherein, the received compound of the formula (I) is
transformed further into a compound of the formula (II)
(Formula Removed)
11. A process as claimed in claim 1, wherein, the formed compound of the formula (I) is
transformed further without isolation into a compound of the formula (II).
12. A process as claimed in claim 9, wherein, the received compound of the formula (I) is
transformed into a compound of the formula (II) by using aqueous alkali cyanide
optionally in the presence of phase-transfer catalyst.
13. A process as claimed in claim 1, wherein the compounds of formula I are used for the
synthesis of different Active Pharmaceutical Ingredients.
14. A process as claimed in claim 10, wherein the compounds of formula II are used for the
synthesis of different Active Pharmaceutical Ingredients.

Documents

Application Documents

# Name Date
1 1744-DELNP-2003-Others-Document-(27-02-2009).pdf 2009-02-27
2 1744-delnp-2003-form-13-(27-02-2009).pdf 2009-02-27
3 1744-DELNP-2003-Correspondence-Others-(27-02-2009).pdf 2009-02-27
4 1744-DELNP-2003-Petition-137-(25-11-2009).pdf 2009-11-25
5 1744-DELNP-2003-GPA-(25-11-2009).pdf 2009-11-25
6 1744-DELNP-2003-Form-3-(25-11-2009).pdf 2009-11-25
7 1744-DELNP-2003-Form-2-(25-11-2009).pdf 2009-11-25
8 1744-DELNP-2003-Form-1-(25-11-2009).pdf 2009-11-25
9 1744-DELNP-2003-Drawings-(25-11-2009).pdf 2009-11-25
10 1744-DELNP-2003-Description (Complete)-(25-11-2009).pdf 2009-11-25
11 1744-DELNP-2003-Correspondence-Others-(25-11-2009).pdf 2009-11-25
12 1744-DELNP-2003-Claims-(25-11-2009).pdf 2009-11-25
13 1744-DELNP-2003-Abstract-(25-11-2009).pdf 2009-11-25
14 PatentNumber-248007.pdf 2011-08-21
15 1744-DELNP-2003FinalGrantedDoc.pdf 2011-08-21
16 1744-delnp-2003-pct-416.pdf 2011-08-21
17 1744-delnp-2003-pct-409.pdf 2011-08-21
18 1744-delnp-2003-pct-408.pdf 2011-08-21
19 1744-delnp-2003-pct-401.pdf 2011-08-21
20 1744-delnp-2003-pct-304.pdf 2011-08-21
21 1744-delnp-2003-pct-210.pdf 2011-08-21
22 1744-delnp-2003-pct-101.pdf 2011-08-21
23 1744-delnp-2003-gpa.pdf 2011-08-21
24 1744-delnp-2003-form-5.pdf 2011-08-21
25 1744-delnp-2003-form-3.pdf 2011-08-21
26 1744-delnp-2003-form-2.pdf 2011-08-21
27 1744-delnp-2003-form-18.pdf 2011-08-21
28 1744-delnp-2003-form-1.pdf 2011-08-21
29 1744-delnp-2003-drawings.pdf 2011-08-21
30 1744-delnp-2003-description (complete).pdf 2011-08-21
31 1744-delnp-2003-correspondence-others.pdf 2011-08-21
32 1744-delnp-2003-claims.pdf 2011-08-21
33 1744-delnp-2003-abstract.pdf 2011-08-21
34 INEXRP-1744-DELNP-2003.pdf 2016-06-30
35 1744-DELNP-2003_EXAMREPORT.pdf 2016-06-30
36 1744-DELNP-2003-PatentCertificateCoverLetter.pdf 2017-08-10
37 1744-DELNP-2003-PatentCertificate10-08-2017.pdf 2017-08-10
38 1744-DELNP-2003-RELEVANT DOCUMENTS [30-03-2018(online)].pdf 2018-03-30
39 1744-DELNP-2003-RELEVANT DOCUMENTS [27-03-2019(online)].pdf 2019-03-27
40 1744-DELNP-2003-RELEVANT DOCUMENTS [18-05-2020(online)].pdf 2020-05-18
41 1744-DELNP-2003-RELEVANT DOCUMENTS [20-05-2020(online)].pdf 2020-05-20

ERegister / Renewals

3rd: 08 Nov 2017

From 16/05/2004 - To 16/05/2005

4th: 08 Nov 2017

From 16/05/2005 - To 16/05/2006

5th: 08 Nov 2017

From 16/05/2006 - To 16/05/2007

6th: 08 Nov 2017

From 16/05/2007 - To 16/05/2008

7th: 08 Nov 2017

From 16/05/2008 - To 16/05/2009

8th: 08 Nov 2017

From 16/05/2009 - To 16/05/2010

9th: 08 Nov 2017

From 16/05/2010 - To 16/05/2011

10th: 08 Nov 2017

From 16/05/2011 - To 16/05/2012

11th: 08 Nov 2017

From 16/05/2012 - To 16/05/2013

12th: 08 Nov 2017

From 16/05/2013 - To 16/05/2014

13th: 08 Nov 2017

From 16/05/2014 - To 16/05/2015

14th: 08 Nov 2017

From 16/05/2015 - To 16/05/2016

15th: 08 Nov 2017

From 16/05/2016 - To 16/05/2017

16th: 08 Nov 2017

From 16/05/2017 - To 16/05/2018

17th: 09 Apr 2018

From 16/05/2018 - To 16/05/2019

18th: 02 Apr 2019

From 16/05/2019 - To 16/05/2020

19th: 14 Apr 2020

From 16/05/2020 - To 16/05/2021